{"id":749,"date":"2026-09-01T16:45:45","date_gmt":"2026-09-01T16:45:45","guid":{"rendered":"https:\/\/nhdbio.com\/resources\/ara-290-cibinetide-small-fiber-neuropathy-and-dme-trials\/"},"modified":"2026-09-01T16:45:45","modified_gmt":"2026-09-01T16:45:45","slug":"ara-290-cibinetide-small-fiber-neuropathy-and-dme-trials","status":"publish","type":"post","link":"https:\/\/nhdbio.com\/es\/ara-290-cibinetide-small-fiber-neuropathy-and-dme-trials\/","title":{"rendered":"ARA-290\/Cibinetida: neuropat\u00eda de fibras peque\u00f1as y datos del ensayo DME"},"content":{"rendered":"<p class=\"pim-standfirst wp-block-paragraph\">La evidencia de cibinetida humana incluye peque\u00f1os estudios exploratorios con poblaciones muy diferentes. Un estudio piloto sobre sarcoidosis y neuropat\u00eda en personas de 22 inform\u00f3 una diferencia en la puntuaci\u00f3n de los s\u00edntomas, mientras que un estudio sobre edema macular diab\u00e9tico en personas de 9 omiti\u00f3 sus principales medidas oculares.<\/p><div class=\"wp-block-group pim-key-takeaways\"><div class=\"wp-block-group__inner-container is-layout-flow wp-block-group-is-layout-flow\"><h2 class=\"wp-block-heading\">Evidencia de un vistazo<\/h2><ul class=\"wp-block-list\"><li>El piloto aleatorizado de sarcoidosis inscribi\u00f3 a participantes de 22: 12 recibi\u00f3 ARA-290 y 10 placebo.<\/li><li>El cambio de SFNSL en la semana 4 fue \u221211.5 \u00b1 3.04 versus \u22122.9 \u00b1 3.34, mientras que las puntuaciones de intensidad del dolor y fatiga mejoraron de manera similar en ambos grupos.<\/li><li>En el estudio DME, se inscribieron 9 y se complet\u00f3 8; La agudeza visual media, el grosor de la retina, la sensibilidad de la retina y la producci\u00f3n de l\u00e1grimas no mejoraron.<\/li><\/ul><\/div><\/div><figure class=\"wp-block-image size-full pim-article-figure\"><img loading=\"lazy\" decoding=\"async\" width=\"1672\" height=\"941\" src=\"http:\/\/nhdbio.com\/wp-content\/uploads\/2026\/09\/cibinetide-small-fiber-evidence.webp\" alt=\"Im\u00e1genes de investigaci\u00f3n de fibras nerviosas peque\u00f1as corneales y perif\u00e9ricas para cibinetida\" class=\"wp-image-733\" srcset=\"https:\/\/nhdbio.com\/wp-content\/uploads\/2026\/09\/cibinetide-small-fiber-evidence.webp 1672w, https:\/\/nhdbio.com\/wp-content\/uploads\/2026\/09\/cibinetide-small-fiber-evidence-300x169.webp 300w, https:\/\/nhdbio.com\/wp-content\/uploads\/2026\/09\/cibinetide-small-fiber-evidence-1024x576.webp 1024w, https:\/\/nhdbio.com\/wp-content\/uploads\/2026\/09\/cibinetide-small-fiber-evidence-768x432.webp 768w, https:\/\/nhdbio.com\/wp-content\/uploads\/2026\/09\/cibinetide-small-fiber-evidence-1536x864.webp 1536w\" sizes=\"auto, (max-width: 1672px) 100vw, 1672px\" \/><figcaption class=\"wp-element-caption\">Ilustraci\u00f3n original de investigaci\u00f3n editorial. No es una figura de estudio, una imagen de un paciente, una fotograf\u00eda de un producto, un resultado de ensayo suministrado ni una representaci\u00f3n de un lote de cat\u00e1logo.<\/figcaption><\/figure><h2 class=\"wp-block-heading\">Registro de estudio<\/h2><p class=\"wp-block-paragraph\">El piloto de neuropat\u00eda inform\u00f3 un cambio estad\u00edsticamente significativo entre grupos en la lista de detecci\u00f3n de neuropat\u00eda de fibras peque\u00f1as. Sin embargo, el Inventario Breve de Dolor y las puntuaciones de fatiga mejoraron significativamente pero de manera equivalente en ambos grupos, y el inventario de depresi\u00f3n no cambi\u00f3.<\/p><div class=\"wp-block-group pim-evidence-table\"><div class=\"wp-block-group__inner-container is-layout-flow wp-block-group-is-layout-flow\"><div class=\"pim-evidence-row\"><strong>Dise\u00f1o de sarcoidosis<\/strong><span>Piloto exploratorio doble ciego controlado con placebo; n=22<\/span><\/div><div class=\"pim-evidence-row\"><strong>cambio SFNSL<\/strong><span>\u221211.5 \u00b1 3.04 versus \u22122.9 \u00b1 3.34 en la semana 4<\/span><\/div><div class=\"pim-evidence-row\"><strong>Dise\u00f1o DME<\/strong><span>Fase de un solo brazo 2; 9 inscrito, 8 completado<\/span><\/div><div class=\"pim-evidence-row\"><strong>DME principales medidas<\/strong><span>No hay mejora significativa en BCVA, CRT, sensibilidad retiniana o producci\u00f3n de l\u00e1grimas.<\/span><\/div><div class=\"pim-evidence-row\"><strong>Interpretaci\u00f3n general<\/strong><span>Las se\u00f1ales generan hip\u00f3tesis, no son confirmatorias.<\/span><\/div><\/div><\/div><h2 class=\"wp-block-heading\">Resultados en contexto<\/h2><p class=\"wp-block-paragraph\">El estudio 2020 sobre edema macular diab\u00e9tico fue a\u00fan m\u00e1s peque\u00f1o. En las semanas 12, el BCVA medio cambi\u00f3 en \u22122.9 \u00b1 5.0, el espesor central de la retina en 10 \u00b1 94.6 \u00b5m y la sensibilidad central de la retina en \u22120.53 \u00b1 1.9 dB. Un compuesto de funci\u00f3n visual informado por el paciente mejor\u00f3 en 2.7 \u00b1 3.1, pero el dise\u00f1o fue descriptivo y no controlado.<\/p><p class=\"wp-block-paragraph\">Varios autores del art\u00edculo DME eran funcionarios, propietarios o consultores del desarrollador. Esa divulgaci\u00f3n no invalida los resultados, pero debe ir al lado de los datos cuando los lectores juzgan un peque\u00f1o ensayo exploratorio.<\/p><h2 class=\"wp-block-heading\">Lo que la evidencia no puede establecer<\/h2><p class=\"wp-block-paragraph\">Las muestras peque\u00f1as y el seguimiento corto hacen que las estimaciones del efecto sean inestables.<\/p><p class=\"wp-block-paragraph\">No se pueden combinar diferentes enfermedades y criterios de valoraci\u00f3n en una afirmaci\u00f3n amplia de \u201creparaci\u00f3n de nervios\u201d.<\/p><p class=\"wp-block-paragraph\">Ninguno de los estudios establece equivalencia con el material de un cat\u00e1logo ni respalda el uso fuera de la investigaci\u00f3n.<\/p>","protected":false},"excerpt":{"rendered":"<p>La evidencia de cibinetida humana incluye peque\u00f1os estudios exploratorios con poblaciones muy diferentes. Un estudio piloto sobre sarcoidosis y neuropat\u00eda en personas de 22 inform\u00f3 una diferencia en la puntuaci\u00f3n de los s\u00edntomas, mientras que un estudio sobre edema macular diab\u00e9tico en personas de 9 omiti\u00f3 sus principales medidas oculares.<\/p>","protected":false},"author":1,"featured_media":733,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"pim_family_ids":"315","pim_article_type":"Published evidence review","pim_evidence_level":"Small exploratory human trials; mixed endpoints and no confirmatory efficacy record","pim_reviewer":"Site evidence editorial team","pim_reviewed_date":"2026-09-02","pim_editorial_note":"Source-checked on 2026-09-02. Null results, study size, model\/population limits and relevant conflicts are retained. This is not medical advice, a customer case or validation of a catalog lot.","pim_review_status":"reviewed","pim_review_reason":"Primary\/regulatory sources, factual claims, numerical results, limitations and product-evidence boundary checked for batch 3.","pim_creation_method":"The editorial workflow began with linked PubMed primary papers, systematic reviews, PubChem identity records and FDA\/DailyMed regulatory records. Population or model, denominators, endpoints, numerical results, null findings, limitations and conflicts were extracted before drafting. AI-assisted drafting and original image generation were used; the final facts and evidence boundaries were checked against the linked records on 2026-09-02. This is not independent peer review.","pim_sources":"[{\"title\":\"Randomized ARA-290 sarcoidosis-neuropathy pilot\",\"url\":\"https:\/\/pubmed.ncbi.nlm.nih.gov\/23168581\/\",\"note\":\"Primary exploratory trial; PMID 23168581.\"},{\"title\":\"Phase 2 cibinetide diabetic macular edema study\",\"url\":\"https:\/\/pubmed.ncbi.nlm.nih.gov\/32674280\/\",\"note\":\"Nine-person study with null principal ocular measures; PMID 32674280.\"},{\"title\":\"PubChem Cibinetide record\",\"url\":\"https:\/\/pubchem.ncbi.nlm.nih.gov\/compound\/Cibinetide\",\"note\":\"Sequence, synonyms, formula and mass; CID 91810664.\"}]","footnotes":""},"categories":[19],"tags":[],"class_list":["post-749","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-published-study-cases"],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v28.0 (Yoast SEO v28.1) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>ARA-290\/Cibinetide: Small-Fiber Neuropathy and DME Trial Data<\/title>\n<meta name=\"description\" content=\"Human cibinetide evidence includes small exploratory studies with very different populations. A 22-person sarcoidosis-neuropathy pilot reported a symptom-s\u2026\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/nhdbio.com\/es\/ara-290-cibinetide-small-fiber-neuropathy-and-dme-trials\/\" \/>\n<meta property=\"og:locale\" content=\"es_ES\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"ARA-290\/Cibinetide: Small-Fiber Neuropathy and DME Trial Data\" \/>\n<meta property=\"og:description\" content=\"Human cibinetide evidence includes small exploratory studies with very different populations. A 22-person sarcoidosis-neuropathy pilot reported a symptom-s\u2026\" \/>\n<meta property=\"og:url\" content=\"https:\/\/nhdbio.com\/es\/ara-290-cibinetide-small-fiber-neuropathy-and-dme-trials\/\" \/>\n<meta property=\"og:site_name\" content=\"NHD\" \/>\n<meta property=\"article:published_time\" content=\"2026-09-01T16:45:45+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/nhdbio.com\/wp-content\/uploads\/2026\/09\/cibinetide-small-fiber-evidence.webp\" \/>\n\t<meta property=\"og:image:width\" content=\"1672\" \/>\n\t<meta property=\"og:image:height\" content=\"941\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/webp\" \/>\n<meta name=\"author\" content=\"NHD Technical Team\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:description\" content=\"Peptide Raw Materials and Custom Peptide Synthesis\" \/>\n<meta name=\"twitter:label1\" content=\"Escrito por\" \/>\n\t<meta name=\"twitter:data1\" content=\"NHD Technical Team\" \/>\n\t<meta name=\"twitter:label2\" content=\"Tiempo de lectura\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minuto\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/nhdbio.com\\\/ara-290-cibinetide-small-fiber-neuropathy-and-dme-trials\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/nhdbio.com\\\/ara-290-cibinetide-small-fiber-neuropathy-and-dme-trials\\\/\"},\"author\":{\"name\":\"NHD Technical Team\",\"@id\":\"https:\\\/\\\/nhdbio.com\\\/#\\\/schema\\\/person\\\/0ffb0dec7fda0f720073fc468fac6fc1\"},\"headline\":\"ARA-290\\\/Cibinetide: Small-Fiber Neuropathy and DME Trial Data\",\"datePublished\":\"2026-09-01T16:45:45+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/nhdbio.com\\\/ara-290-cibinetide-small-fiber-neuropathy-and-dme-trials\\\/\"},\"wordCount\":298,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\\\/\\\/nhdbio.com\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/nhdbio.com\\\/ara-290-cibinetide-small-fiber-neuropathy-and-dme-trials\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/nhdbio.com\\\/wp-content\\\/uploads\\\/2026\\\/09\\\/cibinetide-small-fiber-evidence.webp\",\"articleSection\":[\"Published Study Reviews\"],\"inLanguage\":\"es\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/nhdbio.com\\\/ara-290-cibinetide-small-fiber-neuropathy-and-dme-trials\\\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/nhdbio.com\\\/ara-290-cibinetide-small-fiber-neuropathy-and-dme-trials\\\/\",\"url\":\"https:\\\/\\\/nhdbio.com\\\/ara-290-cibinetide-small-fiber-neuropathy-and-dme-trials\\\/\",\"name\":\"ARA-290\\\/Cibinetide: Small-Fiber Neuropathy and DME Trial Data\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/nhdbio.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/nhdbio.com\\\/ara-290-cibinetide-small-fiber-neuropathy-and-dme-trials\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/nhdbio.com\\\/ara-290-cibinetide-small-fiber-neuropathy-and-dme-trials\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/nhdbio.com\\\/wp-content\\\/uploads\\\/2026\\\/09\\\/cibinetide-small-fiber-evidence.webp\",\"datePublished\":\"2026-09-01T16:45:45+00:00\",\"description\":\"Human cibinetide evidence includes small exploratory studies with very different populations. A 22-person sarcoidosis-neuropathy pilot reported a symptom-s\u2026\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/nhdbio.com\\\/ara-290-cibinetide-small-fiber-neuropathy-and-dme-trials\\\/#breadcrumb\"},\"inLanguage\":\"es\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/nhdbio.com\\\/ara-290-cibinetide-small-fiber-neuropathy-and-dme-trials\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\\\/\\\/nhdbio.com\\\/ara-290-cibinetide-small-fiber-neuropathy-and-dme-trials\\\/#primaryimage\",\"url\":\"https:\\\/\\\/nhdbio.com\\\/wp-content\\\/uploads\\\/2026\\\/09\\\/cibinetide-small-fiber-evidence.webp\",\"contentUrl\":\"https:\\\/\\\/nhdbio.com\\\/wp-content\\\/uploads\\\/2026\\\/09\\\/cibinetide-small-fiber-evidence.webp\",\"width\":1672,\"height\":941,\"caption\":\"AI-generated illustration: Corneal and peripheral small-nerve-fiber research imaging for cibinetide\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/nhdbio.com\\\/ara-290-cibinetide-small-fiber-neuropathy-and-dme-trials\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/nhdbio.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"ARA-290\\\/Cibinetide: Small-Fiber Neuropathy and DME Trial Data\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/nhdbio.com\\\/#website\",\"url\":\"https:\\\/\\\/nhdbio.com\\\/\",\"name\":\"NHD\",\"description\":\"Peptide Raw Materials and Custom Peptide Synthesis\",\"publisher\":{\"@id\":\"https:\\\/\\\/nhdbio.com\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/nhdbio.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"es\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/nhdbio.com\\\/#organization\",\"name\":\"NHD\",\"url\":\"https:\\\/\\\/nhdbio.com\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\\\/\\\/nhdbio.com\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/nhdbio.com\\\/wp-content\\\/uploads\\\/2026\\\/09\\\/codex-clipboard-354c928e-4b5b-482d-9261-02023d4c9680.png\",\"contentUrl\":\"https:\\\/\\\/nhdbio.com\\\/wp-content\\\/uploads\\\/2026\\\/09\\\/codex-clipboard-354c928e-4b5b-482d-9261-02023d4c9680.png\",\"width\":2172,\"height\":724,\"caption\":\"NHD\"},\"image\":{\"@id\":\"https:\\\/\\\/nhdbio.com\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/nhdbio.com\\\/#\\\/schema\\\/person\\\/0ffb0dec7fda0f720073fc468fac6fc1\",\"name\":\"NHD Technical Team\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/8445618b3e2834fa0c7ae1a03a371ed002e9bf8d2cc1cd989dc4a71bb2b66110?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/8445618b3e2834fa0c7ae1a03a371ed002e9bf8d2cc1cd989dc4a71bb2b66110?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/8445618b3e2834fa0c7ae1a03a371ed002e9bf8d2cc1cd989dc4a71bb2b66110?s=96&d=mm&r=g\",\"caption\":\"NHD Technical Team\"},\"description\":\"NHD Technical Team maintains research-use catalog documentation and evidence summaries. Reviewed articles link to peer-reviewed papers, trial registries and regulatory records, retain null findings and study limitations, and distinguish published interventions from catalog materials. AI-assisted drafting may be used for structure; source links and evidence boundaries remain visible. This work is not independent peer review or medical advice.\",\"sameAs\":[\"https:\\\/\\\/nhdbio.com\"],\"url\":\"https:\\\/\\\/nhdbio.com\\\/es\\\/author\\\/qianmiao-technical-team\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"ARA-290\/Cibinetida: neuropat\u00eda de fibras peque\u00f1as y datos del ensayo DME","description":"La evidencia de cibinetida humana incluye peque\u00f1os estudios exploratorios con poblaciones muy diferentes. Un piloto de sarcoidosis-neuropat\u00eda en persona de 22 inform\u00f3 un s\u00edntoma...","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/nhdbio.com\/es\/ara-290-cibinetide-small-fiber-neuropathy-and-dme-trials\/","og_locale":"es_ES","og_type":"article","og_title":"ARA-290\/Cibinetide: Small-Fiber Neuropathy and DME Trial Data","og_description":"Human cibinetide evidence includes small exploratory studies with very different populations. A 22-person sarcoidosis-neuropathy pilot reported a symptom-s\u2026","og_url":"https:\/\/nhdbio.com\/es\/ara-290-cibinetide-small-fiber-neuropathy-and-dme-trials\/","og_site_name":"NHD","article_published_time":"2026-09-01T16:45:45+00:00","og_image":[{"width":1672,"height":941,"url":"https:\/\/nhdbio.com\/wp-content\/uploads\/2026\/09\/cibinetide-small-fiber-evidence.webp","type":"image\/webp"}],"author":"NHD Technical Team","twitter_card":"summary_large_image","twitter_description":"Peptide Raw Materials and Custom Peptide Synthesis","twitter_misc":{"Escrito por":"NHD Technical Team","Tiempo de lectura":"1 minuto"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/nhdbio.com\/ara-290-cibinetide-small-fiber-neuropathy-and-dme-trials\/#article","isPartOf":{"@id":"https:\/\/nhdbio.com\/ara-290-cibinetide-small-fiber-neuropathy-and-dme-trials\/"},"author":{"name":"NHD Technical Team","@id":"https:\/\/nhdbio.com\/#\/schema\/person\/0ffb0dec7fda0f720073fc468fac6fc1"},"headline":"ARA-290\/Cibinetide: Small-Fiber Neuropathy and DME Trial Data","datePublished":"2026-09-01T16:45:45+00:00","mainEntityOfPage":{"@id":"https:\/\/nhdbio.com\/ara-290-cibinetide-small-fiber-neuropathy-and-dme-trials\/"},"wordCount":298,"commentCount":0,"publisher":{"@id":"https:\/\/nhdbio.com\/#organization"},"image":{"@id":"https:\/\/nhdbio.com\/ara-290-cibinetide-small-fiber-neuropathy-and-dme-trials\/#primaryimage"},"thumbnailUrl":"https:\/\/nhdbio.com\/wp-content\/uploads\/2026\/09\/cibinetide-small-fiber-evidence.webp","articleSection":["Published Study Reviews"],"inLanguage":"es","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/nhdbio.com\/ara-290-cibinetide-small-fiber-neuropathy-and-dme-trials\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/nhdbio.com\/ara-290-cibinetide-small-fiber-neuropathy-and-dme-trials\/","url":"https:\/\/nhdbio.com\/ara-290-cibinetide-small-fiber-neuropathy-and-dme-trials\/","name":"ARA-290\/Cibinetida: neuropat\u00eda de fibras peque\u00f1as y datos del ensayo DME","isPartOf":{"@id":"https:\/\/nhdbio.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/nhdbio.com\/ara-290-cibinetide-small-fiber-neuropathy-and-dme-trials\/#primaryimage"},"image":{"@id":"https:\/\/nhdbio.com\/ara-290-cibinetide-small-fiber-neuropathy-and-dme-trials\/#primaryimage"},"thumbnailUrl":"https:\/\/nhdbio.com\/wp-content\/uploads\/2026\/09\/cibinetide-small-fiber-evidence.webp","datePublished":"2026-09-01T16:45:45+00:00","description":"La evidencia de cibinetida humana incluye peque\u00f1os estudios exploratorios con poblaciones muy diferentes. Un piloto de sarcoidosis-neuropat\u00eda en persona de 22 inform\u00f3 un s\u00edntoma...","breadcrumb":{"@id":"https:\/\/nhdbio.com\/ara-290-cibinetide-small-fiber-neuropathy-and-dme-trials\/#breadcrumb"},"inLanguage":"es","potentialAction":[{"@type":"ReadAction","target":["https:\/\/nhdbio.com\/ara-290-cibinetide-small-fiber-neuropathy-and-dme-trials\/"]}]},{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/nhdbio.com\/ara-290-cibinetide-small-fiber-neuropathy-and-dme-trials\/#primaryimage","url":"https:\/\/nhdbio.com\/wp-content\/uploads\/2026\/09\/cibinetide-small-fiber-evidence.webp","contentUrl":"https:\/\/nhdbio.com\/wp-content\/uploads\/2026\/09\/cibinetide-small-fiber-evidence.webp","width":1672,"height":941,"caption":"AI-generated illustration: Corneal and peripheral small-nerve-fiber research imaging for cibinetide"},{"@type":"BreadcrumbList","@id":"https:\/\/nhdbio.com\/ara-290-cibinetide-small-fiber-neuropathy-and-dme-trials\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/nhdbio.com\/"},{"@type":"ListItem","position":2,"name":"ARA-290\/Cibinetide: Small-Fiber Neuropathy and DME Trial Data"}]},{"@type":"WebSite","@id":"https:\/\/nhdbio.com\/#website","url":"https:\/\/nhdbio.com\/","name":"NHD","description":"Materias primas pept\u00eddicas y s\u00edntesis personalizada","publisher":{"@id":"https:\/\/nhdbio.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/nhdbio.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"es"},{"@type":"Organization","@id":"https:\/\/nhdbio.com\/#organization","name":"NHD","url":"https:\/\/nhdbio.com\/","logo":{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/nhdbio.com\/#\/schema\/logo\/image\/","url":"https:\/\/nhdbio.com\/wp-content\/uploads\/2026\/09\/codex-clipboard-354c928e-4b5b-482d-9261-02023d4c9680.png","contentUrl":"https:\/\/nhdbio.com\/wp-content\/uploads\/2026\/09\/codex-clipboard-354c928e-4b5b-482d-9261-02023d4c9680.png","width":2172,"height":724,"caption":"NHD"},"image":{"@id":"https:\/\/nhdbio.com\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/nhdbio.com\/#\/schema\/person\/0ffb0dec7fda0f720073fc468fac6fc1","name":"Equipo t\u00e9cnico de NHD","image":{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/secure.gravatar.com\/avatar\/8445618b3e2834fa0c7ae1a03a371ed002e9bf8d2cc1cd989dc4a71bb2b66110?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/8445618b3e2834fa0c7ae1a03a371ed002e9bf8d2cc1cd989dc4a71bb2b66110?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/8445618b3e2834fa0c7ae1a03a371ed002e9bf8d2cc1cd989dc4a71bb2b66110?s=96&d=mm&r=g","caption":"NHD Technical Team"},"description":"El equipo t\u00e9cnico de NHD mantiene documentaci\u00f3n del cat\u00e1logo de uso de investigaci\u00f3n y res\u00famenes de evidencia. Los art\u00edculos revisados \u200b\u200benlazan con art\u00edculos revisados \u200b\u200bpor pares, registros de ensayos y registros regulatorios, conservan hallazgos nulos y limitaciones de estudios, y distinguen las intervenciones publicadas de los materiales del cat\u00e1logo. Se puede utilizar dibujo asistido por AI para la estructura; los enlaces de fuentes y los l\u00edmites de las pruebas permanecen visibles. Este trabajo no es una revisi\u00f3n por pares independiente ni un consejo m\u00e9dico.","sameAs":["https:\/\/nhdbio.com"],"url":"https:\/\/nhdbio.com\/es\/author\/qianmiao-technical-team\/"}]}},"_links":{"self":[{"href":"https:\/\/nhdbio.com\/es\/wp-json\/wp\/v2\/posts\/749","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/nhdbio.com\/es\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/nhdbio.com\/es\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/nhdbio.com\/es\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/nhdbio.com\/es\/wp-json\/wp\/v2\/comments?post=749"}],"version-history":[{"count":0,"href":"https:\/\/nhdbio.com\/es\/wp-json\/wp\/v2\/posts\/749\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/nhdbio.com\/es\/wp-json\/wp\/v2\/media\/733"}],"wp:attachment":[{"href":"https:\/\/nhdbio.com\/es\/wp-json\/wp\/v2\/media?parent=749"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/nhdbio.com\/es\/wp-json\/wp\/v2\/categories?post=749"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/nhdbio.com\/es\/wp-json\/wp\/v2\/tags?post=749"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}